Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled, double-blind study to evaluate the safety and efficacy of two
doses of DR-3001 in women with overactive bladder who have symptoms of predominant or pure
urge incontinence, urinary urgency and elevated urinary frequency